context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
In June 2024, the Company repaid $ 600 million of 3.50 % senior notes at maturity. | text | 600 | monetaryItemType | text: <entity> 600 </entity> <entity type> monetaryItemType </entity type> <context> In June 2024, the Company repaid $ 600 million of 3.50 % senior notes at maturity. </context> | us-gaap:RepaymentsOfDebt |
In June 2024, the Company repaid $ 600 million of 3.50 % senior notes at maturity. | text | 3.50 | percentItemType | text: <entity> 3.50 </entity> <entity type> percentItemType </entity type> <context> In June 2024, the Company repaid $ 600 million of 3.50 % senior notes at maturity. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
In March 2024, the Company repaid $ 1 billion of 3.875 % senior notes at maturity. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> In March 2024, the Company repaid $ 1 billion of 3.875 % senior notes at maturity. </context> | us-gaap:RepaymentsOfDebt |
In March 2024, the Company repaid $ 1 billion of 3.875 % senior notes at maturity. | text | 3.875 | percentItemType | text: <entity> 3.875 </entity> <entity type> percentItemType </entity type> <context> In March 2024, the Company repaid $ 1 billion of 3.875 % senior notes at maturity. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
In February 2024, the Company issued $ 500 million of 5.150 % senior notes due 2034 and $ 500 million of 5.450 % senior notes due 2054. The Company used the net proceeds from these issuances for general corporate purposes. | text | 500 | monetaryItemType | text: <entity> 500 </entity> <entity type> monetaryItemType </entity type> <context> In February 2024, the Company issued $ 500 million of 5.150 % senior notes due 2034 and $ 500 million of 5.450 % senior notes due 2054. The Company used the net proceeds from these issuances for general corporate purposes. </context> | us-gaap:DebtInstrumentFaceAmount |
In February 2024, the Company issued $ 500 million of 5.150 % senior notes due 2034 and $ 500 million of 5.450 % senior notes due 2054. The Company used the net proceeds from these issuances for general corporate purposes. | text | 5.150 | percentItemType | text: <entity> 5.150 </entity> <entity type> percentItemType </entity type> <context> In February 2024, the Company issued $ 500 million of 5.150 % senior notes due 2034 and $ 500 million of 5.450 % senior notes due 2054. The Company used the net proceeds from these issuances for general corporate purposes. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
In February 2024, the Company issued $ 500 million of 5.150 % senior notes due 2034 and $ 500 million of 5.450 % senior notes due 2054. The Company used the net proceeds from these issuances for general corporate purposes. | text | 5.450 | percentItemType | text: <entity> 5.450 </entity> <entity type> percentItemType </entity type> <context> In February 2024, the Company issued $ 500 million of 5.150 % senior notes due 2034 and $ 500 million of 5.450 % senior notes due 2054. The Company used the net proceeds from these issuances for general corporate purposes. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
In October 2023, the Company repaid $ 250 million of 4.05 % senior notes at maturity. | text | 250 | monetaryItemType | text: <entity> 250 </entity> <entity type> monetaryItemType </entity type> <context> In October 2023, the Company repaid $ 250 million of 4.05 % senior notes at maturity. </context> | us-gaap:RepaymentsOfDebt |
In October 2023, the Company repaid $ 250 million of 4.05 % senior notes at maturity. | text | 4.05 | percentItemType | text: <entity> 4.05 </entity> <entity type> percentItemType </entity type> <context> In October 2023, the Company repaid $ 250 million of 4.05 % senior notes at maturity. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
In September 2023, the Company issued $ 600 million of 5.400 % senior notes due 2033 and $ 1 billion of 5.700 % senior notes due 2053. In March 2023, the Company issued $ 600 million of 5.450 % senior notes due 2053. The Company used the net proceeds from these issuances for general corporate purposes. | text | 600 | monetaryItemType | text: <entity> 600 </entity> <entity type> monetaryItemType </entity type> <context> In September 2023, the Company issued $ 600 million of 5.400 % senior notes due 2033 and $ 1 billion of 5.700 % senior notes due 2053. In March 2023, the Company issued $ 600 million of 5.450 % senior notes due 2053. The Company used the net proceeds from these issuances for general corporate purposes. </context> | us-gaap:DebtInstrumentFaceAmount |
In September 2023, the Company issued $ 600 million of 5.400 % senior notes due 2033 and $ 1 billion of 5.700 % senior notes due 2053. In March 2023, the Company issued $ 600 million of 5.450 % senior notes due 2053. The Company used the net proceeds from these issuances for general corporate purposes. | text | 5.400 | percentItemType | text: <entity> 5.400 </entity> <entity type> percentItemType </entity type> <context> In September 2023, the Company issued $ 600 million of 5.400 % senior notes due 2033 and $ 1 billion of 5.700 % senior notes due 2053. In March 2023, the Company issued $ 600 million of 5.450 % senior notes due 2053. The Company used the net proceeds from these issuances for general corporate purposes. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
In September 2023, the Company issued $ 600 million of 5.400 % senior notes due 2033 and $ 1 billion of 5.700 % senior notes due 2053. In March 2023, the Company issued $ 600 million of 5.450 % senior notes due 2053. The Company used the net proceeds from these issuances for general corporate purposes. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> In September 2023, the Company issued $ 600 million of 5.400 % senior notes due 2033 and $ 1 billion of 5.700 % senior notes due 2053. In March 2023, the Company issued $ 600 million of 5.450 % senior notes due 2053. The Company used the net proceeds from these issuances for general corporate purposes. </context> | us-gaap:DebtInstrumentFaceAmount |
In September 2023, the Company issued $ 600 million of 5.400 % senior notes due 2033 and $ 1 billion of 5.700 % senior notes due 2053. In March 2023, the Company issued $ 600 million of 5.450 % senior notes due 2053. The Company used the net proceeds from these issuances for general corporate purposes. | text | 5.700 | percentItemType | text: <entity> 5.700 </entity> <entity type> percentItemType </entity type> <context> In September 2023, the Company issued $ 600 million of 5.400 % senior notes due 2033 and $ 1 billion of 5.700 % senior notes due 2053. In March 2023, the Company issued $ 600 million of 5.450 % senior notes due 2053. The Company used the net proceeds from these issuances for general corporate purposes. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
In September 2023, the Company issued $ 600 million of 5.400 % senior notes due 2033 and $ 1 billion of 5.700 % senior notes due 2053. In March 2023, the Company issued $ 600 million of 5.450 % senior notes due 2053. The Company used the net proceeds from these issuances for general corporate purposes. | text | 5.450 | percentItemType | text: <entity> 5.450 </entity> <entity type> percentItemType </entity type> <context> In September 2023, the Company issued $ 600 million of 5.400 % senior notes due 2033 and $ 1 billion of 5.700 % senior notes due 2053. In March 2023, the Company issued $ 600 million of 5.450 % senior notes due 2053. The Company used the net proceeds from these issuances for general corporate purposes. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
$ 1.3 billion, $ 22 million and $ 1.5 billion | text | 1.3 | monetaryItemType | text: <entity> 1.3 </entity> <entity type> monetaryItemType </entity type> <context> $ 1.3 billion, $ 22 million and $ 1.5 billion </context> | us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree |
$ 1.3 billion, $ 22 million and $ 1.5 billion | text | 22 | monetaryItemType | text: <entity> 22 </entity> <entity type> monetaryItemType </entity type> <context> $ 1.3 billion, $ 22 million and $ 1.5 billion </context> | us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour |
$ 1.3 billion, $ 22 million and $ 1.5 billion | text | 1.5 | monetaryItemType | text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> $ 1.3 billion, $ 22 million and $ 1.5 billion </context> | us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive |
In connection with the McGriff Transaction, on September 29, 2024, the Company entered into a Bridge Loan Commitment Letter (the “Commitment Letter”) to provide the Company under a 364-day unsecured bridge term loan facility in an amount not to exceed $ 7.75 billion (the “Bridge Loan Facility”). The Company paid approximately $ 23 million for customary upfront fees related to the Commitment Letter, amortized as interest expense. On November 8, 2024, the Company terminated the Commitment Letter. | text | 7.75 | monetaryItemType | text: <entity> 7.75 </entity> <entity type> monetaryItemType </entity type> <context> In connection with the McGriff Transaction, on September 29, 2024, the Company entered into a Bridge Loan Commitment Letter (the “Commitment Letter”) to provide the Company under a 364-day unsecured bridge term loan facility in an amount not to exceed $ 7.75 billion (the “Bridge Loan Facility”). The Company paid approximately $ 23 million for customary upfront fees related to the Commitment Letter, amortized as interest expense. On November 8, 2024, the Company terminated the Commitment Letter. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
In connection with the McGriff Transaction, on September 29, 2024, the Company entered into a Bridge Loan Commitment Letter (the “Commitment Letter”) to provide the Company under a 364-day unsecured bridge term loan facility in an amount not to exceed $ 7.75 billion (the “Bridge Loan Facility”). The Company paid approximately $ 23 million for customary upfront fees related to the Commitment Letter, amortized as interest expense. On November 8, 2024, the Company terminated the Commitment Letter. | text | 23 | monetaryItemType | text: <entity> 23 </entity> <entity type> monetaryItemType </entity type> <context> In connection with the McGriff Transaction, on September 29, 2024, the Company entered into a Bridge Loan Commitment Letter (the “Commitment Letter”) to provide the Company under a 364-day unsecured bridge term loan facility in an amount not to exceed $ 7.75 billion (the “Bridge Loan Facility”). The Company paid approximately $ 23 million for customary upfront fees related to the Commitment Letter, amortized as interest expense. On November 8, 2024, the Company terminated the Commitment Letter. </context> | us-gaap:PaymentsOfFinancingCosts |
In the fourth quarter of 2022, the Company initiated activities focused on workforce actions, rationalization of technology and functional services, and reductions in real estate. The Company completed these activities at the end of 2024. The Company has incurred approximately $ 660 million of these restructuring costs through December 31, 2024, primarily severance and lease exit charges, of which $ 221 million were incurred in 2024. | text | 660 | monetaryItemType | text: <entity> 660 </entity> <entity type> monetaryItemType </entity type> <context> In the fourth quarter of 2022, the Company initiated activities focused on workforce actions, rationalization of technology and functional services, and reductions in real estate. The Company completed these activities at the end of 2024. The Company has incurred approximately $ 660 million of these restructuring costs through December 31, 2024, primarily severance and lease exit charges, of which $ 221 million were incurred in 2024. </context> | us-gaap:RestructuringAndRelatedCostCostIncurredToDate1 |
In the fourth quarter of 2022, the Company initiated activities focused on workforce actions, rationalization of technology and functional services, and reductions in real estate. The Company completed these activities at the end of 2024. The Company has incurred approximately $ 660 million of these restructuring costs through December 31, 2024, primarily severance and lease exit charges, of which $ 221 million were incurred in 2024. | text | 221 | monetaryItemType | text: <entity> 221 </entity> <entity type> monetaryItemType </entity type> <context> In the fourth quarter of 2022, the Company initiated activities focused on workforce actions, rationalization of technology and functional services, and reductions in real estate. The Company completed these activities at the end of 2024. The Company has incurred approximately $ 660 million of these restructuring costs through December 31, 2024, primarily severance and lease exit charges, of which $ 221 million were incurred in 2024. </context> | us-gaap:RestructuringCharges |
In 2024, the Company repurchased 4.3 million shares of its common stock for $ 900 million. At December 31, 2024, the Company remained authorized to repurchase up to approximately $ 2.3 billion in shares of its common stock. There is no time limit on the authorization. In 2023, the Company repurchased 6.4 million shares of its common stock for $ 1.15 billion. | text | 4.3 | sharesItemType | text: <entity> 4.3 </entity> <entity type> sharesItemType </entity type> <context> In 2024, the Company repurchased 4.3 million shares of its common stock for $ 900 million. At December 31, 2024, the Company remained authorized to repurchase up to approximately $ 2.3 billion in shares of its common stock. There is no time limit on the authorization. In 2023, the Company repurchased 6.4 million shares of its common stock for $ 1.15 billion. </context> | us-gaap:TreasuryStockSharesAcquired |
In 2024, the Company repurchased 4.3 million shares of its common stock for $ 900 million. At December 31, 2024, the Company remained authorized to repurchase up to approximately $ 2.3 billion in shares of its common stock. There is no time limit on the authorization. In 2023, the Company repurchased 6.4 million shares of its common stock for $ 1.15 billion. | text | 900 | monetaryItemType | text: <entity> 900 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, the Company repurchased 4.3 million shares of its common stock for $ 900 million. At December 31, 2024, the Company remained authorized to repurchase up to approximately $ 2.3 billion in shares of its common stock. There is no time limit on the authorization. In 2023, the Company repurchased 6.4 million shares of its common stock for $ 1.15 billion. </context> | us-gaap:TreasuryStockValueAcquiredCostMethod |
In 2024, the Company repurchased 4.3 million shares of its common stock for $ 900 million. At December 31, 2024, the Company remained authorized to repurchase up to approximately $ 2.3 billion in shares of its common stock. There is no time limit on the authorization. In 2023, the Company repurchased 6.4 million shares of its common stock for $ 1.15 billion. | text | 2.3 | monetaryItemType | text: <entity> 2.3 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, the Company repurchased 4.3 million shares of its common stock for $ 900 million. At December 31, 2024, the Company remained authorized to repurchase up to approximately $ 2.3 billion in shares of its common stock. There is no time limit on the authorization. In 2023, the Company repurchased 6.4 million shares of its common stock for $ 1.15 billion. </context> | us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 |
In 2024, the Company repurchased 4.3 million shares of its common stock for $ 900 million. At December 31, 2024, the Company remained authorized to repurchase up to approximately $ 2.3 billion in shares of its common stock. There is no time limit on the authorization. In 2023, the Company repurchased 6.4 million shares of its common stock for $ 1.15 billion. | text | 6.4 | sharesItemType | text: <entity> 6.4 </entity> <entity type> sharesItemType </entity type> <context> In 2024, the Company repurchased 4.3 million shares of its common stock for $ 900 million. At December 31, 2024, the Company remained authorized to repurchase up to approximately $ 2.3 billion in shares of its common stock. There is no time limit on the authorization. In 2023, the Company repurchased 6.4 million shares of its common stock for $ 1.15 billion. </context> | us-gaap:TreasuryStockSharesAcquired |
In 2024, the Company repurchased 4.3 million shares of its common stock for $ 900 million. At December 31, 2024, the Company remained authorized to repurchase up to approximately $ 2.3 billion in shares of its common stock. There is no time limit on the authorization. In 2023, the Company repurchased 6.4 million shares of its common stock for $ 1.15 billion. | text | 1.15 | monetaryItemType | text: <entity> 1.15 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, the Company repurchased 4.3 million shares of its common stock for $ 900 million. At December 31, 2024, the Company remained authorized to repurchase up to approximately $ 2.3 billion in shares of its common stock. There is no time limit on the authorization. In 2023, the Company repurchased 6.4 million shares of its common stock for $ 1.15 billion. </context> | us-gaap:TreasuryStockValueAcquiredCostMethod |
The Company issued approximately 3.7 million and 3.6 million shares related to stock compensation and employee stock purchase plans for the years ended December 31, 2024 and 2023, respectively. | text | 3.7 | sharesItemType | text: <entity> 3.7 </entity> <entity type> sharesItemType </entity type> <context> The Company issued approximately 3.7 million and 3.6 million shares related to stock compensation and employee stock purchase plans for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod |
The Company issued approximately 3.7 million and 3.6 million shares related to stock compensation and employee stock purchase plans for the years ended December 31, 2024 and 2023, respectively. | text | 3.6 | sharesItemType | text: <entity> 3.6 </entity> <entity type> sharesItemType </entity type> <context> The Company issued approximately 3.7 million and 3.6 million shares related to stock compensation and employee stock purchase plans for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod |
In January 2025, the Board of Directors of the Company declared a quarterly dividend of $ 0.815 per share on outstanding common stock, payable in February 2025. | text | 0.815 | perShareItemType | text: <entity> 0.815 </entity> <entity type> perShareItemType </entity type> <context> In January 2025, the Board of Directors of the Company declared a quarterly dividend of $ 0.815 per share on outstanding common stock, payable in February 2025. </context> | us-gaap:CommonStockDividendsPerShareDeclared |
Includes interest income on fiduciary funds of $ 497 million, $ 453 million and $ 120 million in 2024, 2023 and 2022, respectively, and equity method income of $ 22 million, $ 18 million and $ 12 million in 2024, 2023 and 2022, respectively. Revenue in 2023 includes a gain from a legal settlement with a competitor of $ 58 million, excluding legal fees. | text | 22 | monetaryItemType | text: <entity> 22 </entity> <entity type> monetaryItemType </entity type> <context> Includes interest income on fiduciary funds of $ 497 million, $ 453 million and $ 120 million in 2024, 2023 and 2022, respectively, and equity method income of $ 22 million, $ 18 million and $ 12 million in 2024, 2023 and 2022, respectively. Revenue in 2023 includes a gain from a legal settlement with a competitor of $ 58 million, excluding legal fees. </context> | us-gaap:IncomeLossFromEquityMethodInvestments |
Includes interest income on fiduciary funds of $ 497 million, $ 453 million and $ 120 million in 2024, 2023 and 2022, respectively, and equity method income of $ 22 million, $ 18 million and $ 12 million in 2024, 2023 and 2022, respectively. Revenue in 2023 includes a gain from a legal settlement with a competitor of $ 58 million, excluding legal fees. | text | 18 | monetaryItemType | text: <entity> 18 </entity> <entity type> monetaryItemType </entity type> <context> Includes interest income on fiduciary funds of $ 497 million, $ 453 million and $ 120 million in 2024, 2023 and 2022, respectively, and equity method income of $ 22 million, $ 18 million and $ 12 million in 2024, 2023 and 2022, respectively. Revenue in 2023 includes a gain from a legal settlement with a competitor of $ 58 million, excluding legal fees. </context> | us-gaap:IncomeLossFromEquityMethodInvestments |
Includes interest income on fiduciary funds of $ 497 million, $ 453 million and $ 120 million in 2024, 2023 and 2022, respectively, and equity method income of $ 22 million, $ 18 million and $ 12 million in 2024, 2023 and 2022, respectively. Revenue in 2023 includes a gain from a legal settlement with a competitor of $ 58 million, excluding legal fees. | text | 12 | monetaryItemType | text: <entity> 12 </entity> <entity type> monetaryItemType </entity type> <context> Includes interest income on fiduciary funds of $ 497 million, $ 453 million and $ 120 million in 2024, 2023 and 2022, respectively, and equity method income of $ 22 million, $ 18 million and $ 12 million in 2024, 2023 and 2022, respectively. Revenue in 2023 includes a gain from a legal settlement with a competitor of $ 58 million, excluding legal fees. </context> | us-gaap:IncomeLossFromEquityMethodInvestments |
Includes interest income on fiduciary funds of $ 497 million, $ 453 million and $ 120 million in 2024, 2023 and 2022, respectively, and equity method income of $ 22 million, $ 18 million and $ 12 million in 2024, 2023 and 2022, respectively. Revenue in 2023 includes a gain from a legal settlement with a competitor of $ 58 million, excluding legal fees. | text | 58 | monetaryItemType | text: <entity> 58 </entity> <entity type> monetaryItemType </entity type> <context> Includes interest income on fiduciary funds of $ 497 million, $ 453 million and $ 120 million in 2024, 2023 and 2022, respectively, and equity method income of $ 22 million, $ 18 million and $ 12 million in 2024, 2023 and 2022, respectively. Revenue in 2023 includes a gain from a legal settlement with a competitor of $ 58 million, excluding legal fees. </context> | us-gaap:GainLossRelatedToLitigationSettlement |
Includes inter-segment revenue of $ 60 million, $ 56 million and $ 59 million in 2024, 2023 and 2022, respectively. Revenue in 2024 includes a net gain on the sale of the Mercer U.K. pension administration and U.S. health and benefits administration business of $ 35 million. Revenue in 2022 includes a net gain on the sale of the Mercer U.S. affinity business of $ 112 million. | text | 60 | monetaryItemType | text: <entity> 60 </entity> <entity type> monetaryItemType </entity type> <context> Includes inter-segment revenue of $ 60 million, $ 56 million and $ 59 million in 2024, 2023 and 2022, respectively. Revenue in 2024 includes a net gain on the sale of the Mercer U.K. pension administration and U.S. health and benefits administration business of $ 35 million. Revenue in 2022 includes a net gain on the sale of the Mercer U.S. affinity business of $ 112 million. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Includes inter-segment revenue of $ 60 million, $ 56 million and $ 59 million in 2024, 2023 and 2022, respectively. Revenue in 2024 includes a net gain on the sale of the Mercer U.K. pension administration and U.S. health and benefits administration business of $ 35 million. Revenue in 2022 includes a net gain on the sale of the Mercer U.S. affinity business of $ 112 million. | text | 56 | monetaryItemType | text: <entity> 56 </entity> <entity type> monetaryItemType </entity type> <context> Includes inter-segment revenue of $ 60 million, $ 56 million and $ 59 million in 2024, 2023 and 2022, respectively. Revenue in 2024 includes a net gain on the sale of the Mercer U.K. pension administration and U.S. health and benefits administration business of $ 35 million. Revenue in 2022 includes a net gain on the sale of the Mercer U.S. affinity business of $ 112 million. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Includes inter-segment revenue of $ 60 million, $ 56 million and $ 59 million in 2024, 2023 and 2022, respectively. Revenue in 2024 includes a net gain on the sale of the Mercer U.K. pension administration and U.S. health and benefits administration business of $ 35 million. Revenue in 2022 includes a net gain on the sale of the Mercer U.S. affinity business of $ 112 million. | text | 59 | monetaryItemType | text: <entity> 59 </entity> <entity type> monetaryItemType </entity type> <context> Includes inter-segment revenue of $ 60 million, $ 56 million and $ 59 million in 2024, 2023 and 2022, respectively. Revenue in 2024 includes a net gain on the sale of the Mercer U.K. pension administration and U.S. health and benefits administration business of $ 35 million. Revenue in 2022 includes a net gain on the sale of the Mercer U.S. affinity business of $ 112 million. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Includes inter-segment revenue of $ 60 million, $ 56 million and $ 59 million in 2024, 2023 and 2022, respectively. Revenue in 2024 includes a net gain on the sale of the Mercer U.K. pension administration and U.S. health and benefits administration business of $ 35 million. Revenue in 2022 includes a net gain on the sale of the Mercer U.S. affinity business of $ 112 million. | text | 35 | monetaryItemType | text: <entity> 35 </entity> <entity type> monetaryItemType </entity type> <context> Includes inter-segment revenue of $ 60 million, $ 56 million and $ 59 million in 2024, 2023 and 2022, respectively. Revenue in 2024 includes a net gain on the sale of the Mercer U.K. pension administration and U.S. health and benefits administration business of $ 35 million. Revenue in 2022 includes a net gain on the sale of the Mercer U.S. affinity business of $ 112 million. </context> | us-gaap:GainLossOnSaleOfBusiness |
Includes inter-segment revenue of $ 60 million, $ 56 million and $ 59 million in 2024, 2023 and 2022, respectively. Revenue in 2024 includes a net gain on the sale of the Mercer U.K. pension administration and U.S. health and benefits administration business of $ 35 million. Revenue in 2022 includes a net gain on the sale of the Mercer U.S. affinity business of $ 112 million. | text | 112 | monetaryItemType | text: <entity> 112 </entity> <entity type> monetaryItemType </entity type> <context> Includes inter-segment revenue of $ 60 million, $ 56 million and $ 59 million in 2024, 2023 and 2022, respectively. Revenue in 2024 includes a net gain on the sale of the Mercer U.K. pension administration and U.S. health and benefits administration business of $ 35 million. Revenue in 2022 includes a net gain on the sale of the Mercer U.S. affinity business of $ 112 million. </context> | us-gaap:GainLossOnSaleOfBusiness |
Revenue in 2024 includes the loss on the sale of the Mercer U.S. health and benefits administration business of $ 35 million. Revenue in 2022 includes a net gain from the sale of the Mercer U.S. affinity business of $ 112 million. | text | 35 | monetaryItemType | text: <entity> 35 </entity> <entity type> monetaryItemType </entity type> <context> Revenue in 2024 includes the loss on the sale of the Mercer U.S. health and benefits administration business of $ 35 million. Revenue in 2022 includes a net gain from the sale of the Mercer U.S. affinity business of $ 112 million. </context> | us-gaap:GainLossOnSaleOfBusiness |
Revenue in 2024 includes the loss on the sale of the Mercer U.S. health and benefits administration business of $ 35 million. Revenue in 2022 includes a net gain from the sale of the Mercer U.S. affinity business of $ 112 million. | text | 112 | monetaryItemType | text: <entity> 112 </entity> <entity type> monetaryItemType </entity type> <context> Revenue in 2024 includes the loss on the sale of the Mercer U.S. health and benefits administration business of $ 35 million. Revenue in 2022 includes a net gain from the sale of the Mercer U.S. affinity business of $ 112 million. </context> | us-gaap:GainLossOnSaleOfBusiness |
Revenue in 2024 includes the gain on the sale of the Mercer U.K. pension administration business of $ 70 million. Revenue in 2023 includes a gain from a legal settlement with a competitor of $ 58 million, excluding legal fees. | text | 70 | monetaryItemType | text: <entity> 70 </entity> <entity type> monetaryItemType </entity type> <context> Revenue in 2024 includes the gain on the sale of the Mercer U.K. pension administration business of $ 70 million. Revenue in 2023 includes a gain from a legal settlement with a competitor of $ 58 million, excluding legal fees. </context> | us-gaap:GainLossOnSaleOfBusiness |
Revenue in 2024 includes the gain on the sale of the Mercer U.K. pension administration business of $ 70 million. Revenue in 2023 includes a gain from a legal settlement with a competitor of $ 58 million, excluding legal fees. | text | 58 | monetaryItemType | text: <entity> 58 </entity> <entity type> monetaryItemType </entity type> <context> Revenue in 2024 includes the gain on the sale of the Mercer U.K. pension administration business of $ 70 million. Revenue in 2023 includes a gain from a legal settlement with a competitor of $ 58 million, excluding legal fees. </context> | us-gaap:GainLossRelatedToLitigationSettlement |
As of December 31, 2024 the Company had no investments. As of December 31, 2023 the Company considered investments in corporate bonds, agency bonds, treasury bills and commercial paper as available-for-sale securities based on the Company’s intent for the respective securities . Available-for-sale securities are carried at fair value, determined using Level 1 and Level 2 of the hierarchy of valuation inputs, with the use of quoted market prices and inputs other than quoted prices that are observable for the assets. Unrealized investment gains and losses, net of tax, are reported as a separate component of other comprehensive income. Unrealized losses considered to be other-than temporary are recognized currently in earnings. Amortization of premiums, accretion of discounts, interest and dividend income and realized gains and losses are included in interest and other income. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 the Company had no investments. As of December 31, 2023 the Company considered investments in corporate bonds, agency bonds, treasury bills and commercial paper as available-for-sale securities based on the Company’s intent for the respective securities . Available-for-sale securities are carried at fair value, determined using Level 1 and Level 2 of the hierarchy of valuation inputs, with the use of quoted market prices and inputs other than quoted prices that are observable for the assets. Unrealized investment gains and losses, net of tax, are reported as a separate component of other comprehensive income. Unrealized losses considered to be other-than temporary are recognized currently in earnings. Amortization of premiums, accretion of discounts, interest and dividend income and realized gains and losses are included in interest and other income. </context> | us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent |
Costs that are capitalized include payroll and payroll-related costs for employees who are directly associated and spend time producing content and payments to faculty and subject matter experts involved in the process. The Company starts capitalizing content costs when it begins to develop or to convert a particular course, resources have been assigned and a timeline has been set. The content asset is placed in service when all work is complete and the curriculum could be used for instruction. Capitalized content development assets are included in other assets in our consolidated balance sheets. The Company has concluded that the most appropriate method to amortize the deferred content assets is on a straight-line basis over the estimated life of the course, which is generally four years which corresponds with course’s review and major revision cycle. As of December 31, 2024 and 2023, $ 658 and $ 746 , respectively, net of amortization, of deferred content assets are included in other assets in the Company’s consolidated balance sheets and amortization is included in technical and academic services where the costs originated. | text | 658 | monetaryItemType | text: <entity> 658 </entity> <entity type> monetaryItemType </entity type> <context> Costs that are capitalized include payroll and payroll-related costs for employees who are directly associated and spend time producing content and payments to faculty and subject matter experts involved in the process. The Company starts capitalizing content costs when it begins to develop or to convert a particular course, resources have been assigned and a timeline has been set. The content asset is placed in service when all work is complete and the curriculum could be used for instruction. Capitalized content development assets are included in other assets in our consolidated balance sheets. The Company has concluded that the most appropriate method to amortize the deferred content assets is on a straight-line basis over the estimated life of the course, which is generally four years which corresponds with course’s review and major revision cycle. As of December 31, 2024 and 2023, $ 658 and $ 746 , respectively, net of amortization, of deferred content assets are included in other assets in the Company’s consolidated balance sheets and amortization is included in technical and academic services where the costs originated. </context> | us-gaap:OtherAssetsNoncurrent |
Costs that are capitalized include payroll and payroll-related costs for employees who are directly associated and spend time producing content and payments to faculty and subject matter experts involved in the process. The Company starts capitalizing content costs when it begins to develop or to convert a particular course, resources have been assigned and a timeline has been set. The content asset is placed in service when all work is complete and the curriculum could be used for instruction. Capitalized content development assets are included in other assets in our consolidated balance sheets. The Company has concluded that the most appropriate method to amortize the deferred content assets is on a straight-line basis over the estimated life of the course, which is generally four years which corresponds with course’s review and major revision cycle. As of December 31, 2024 and 2023, $ 658 and $ 746 , respectively, net of amortization, of deferred content assets are included in other assets in the Company’s consolidated balance sheets and amortization is included in technical and academic services where the costs originated. | text | 746 | monetaryItemType | text: <entity> 746 </entity> <entity type> monetaryItemType </entity type> <context> Costs that are capitalized include payroll and payroll-related costs for employees who are directly associated and spend time producing content and payments to faculty and subject matter experts involved in the process. The Company starts capitalizing content costs when it begins to develop or to convert a particular course, resources have been assigned and a timeline has been set. The content asset is placed in service when all work is complete and the curriculum could be used for instruction. Capitalized content development assets are included in other assets in our consolidated balance sheets. The Company has concluded that the most appropriate method to amortize the deferred content assets is on a straight-line basis over the estimated life of the course, which is generally four years which corresponds with course’s review and major revision cycle. As of December 31, 2024 and 2023, $ 658 and $ 746 , respectively, net of amortization, of deferred content assets are included in other assets in the Company’s consolidated balance sheets and amortization is included in technical and academic services where the costs originated. </context> | us-gaap:OtherAssetsNoncurrent |
Goodwill represents the excess of the purchase price of an acquired business over the amount assigned to the tangible and intangible assets acquired and liabilities assumed. Goodwill is assessed at least annually for impairment during the fourth quarter, or more frequently if circumstances indicate potential impairment. Goodwill is allocated to our reporting unit at the education services segment, which is the same as the entity as a whole (entity level reporting unit). The Company has concluded there is one operating segment and one reporting unit for goodwill impairment consideration. The Financial Accounting Standards Board (“FASB”) has issued guidance that permits an entity to first assess qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. The Company reviews goodwill at least annually or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Following this assessment, the Company determined that it is more likely than not that its fair value exceeds its carrying amount. | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> Goodwill represents the excess of the purchase price of an acquired business over the amount assigned to the tangible and intangible assets acquired and liabilities assumed. Goodwill is assessed at least annually for impairment during the fourth quarter, or more frequently if circumstances indicate potential impairment. Goodwill is allocated to our reporting unit at the education services segment, which is the same as the entity as a whole (entity level reporting unit). The Company has concluded there is one operating segment and one reporting unit for goodwill impairment consideration. The Financial Accounting Standards Board (“FASB”) has issued guidance that permits an entity to first assess qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. The Company reviews goodwill at least annually or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Following this assessment, the Company determined that it is more likely than not that its fair value exceeds its carrying amount. </context> | us-gaap:NumberOfOperatingSegments |
Goodwill represents the excess of the purchase price of an acquired business over the amount assigned to the tangible and intangible assets acquired and liabilities assumed. Goodwill is assessed at least annually for impairment during the fourth quarter, or more frequently if circumstances indicate potential impairment. Goodwill is allocated to our reporting unit at the education services segment, which is the same as the entity as a whole (entity level reporting unit). The Company has concluded there is one operating segment and one reporting unit for goodwill impairment consideration. The Financial Accounting Standards Board (“FASB”) has issued guidance that permits an entity to first assess qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. The Company reviews goodwill at least annually or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Following this assessment, the Company determined that it is more likely than not that its fair value exceeds its carrying amount. | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> Goodwill represents the excess of the purchase price of an acquired business over the amount assigned to the tangible and intangible assets acquired and liabilities assumed. Goodwill is assessed at least annually for impairment during the fourth quarter, or more frequently if circumstances indicate potential impairment. Goodwill is allocated to our reporting unit at the education services segment, which is the same as the entity as a whole (entity level reporting unit). The Company has concluded there is one operating segment and one reporting unit for goodwill impairment consideration. The Financial Accounting Standards Board (“FASB”) has issued guidance that permits an entity to first assess qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. The Company reviews goodwill at least annually or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Following this assessment, the Company determined that it is more likely than not that its fair value exceeds its carrying amount. </context> | us-gaap:NumberOfReportingUnits |
The Company applies a more-likely-than-not threshold for financial statement recognition and measurement of an uncertain tax position taken or expected to be taken in a tax return. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. As of December 31, 2024 and 2023, the Company has reserved approximately $ 14,626 and $ 13,631 , respectively, for uncertain tax positions, including interest and penalties, which is classified within accrued liabilities on the accompanying consolidated balance sheet. | text | 14626 | monetaryItemType | text: <entity> 14626 </entity> <entity type> monetaryItemType </entity type> <context> The Company applies a more-likely-than-not threshold for financial statement recognition and measurement of an uncertain tax position taken or expected to be taken in a tax return. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. As of December 31, 2024 and 2023, the Company has reserved approximately $ 14,626 and $ 13,631 , respectively, for uncertain tax positions, including interest and penalties, which is classified within accrued liabilities on the accompanying consolidated balance sheet. </context> | us-gaap:LiabilityForUncertainTaxPositionsCurrent |
The Company applies a more-likely-than-not threshold for financial statement recognition and measurement of an uncertain tax position taken or expected to be taken in a tax return. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. As of December 31, 2024 and 2023, the Company has reserved approximately $ 14,626 and $ 13,631 , respectively, for uncertain tax positions, including interest and penalties, which is classified within accrued liabilities on the accompanying consolidated balance sheet. | text | 13631 | monetaryItemType | text: <entity> 13631 </entity> <entity type> monetaryItemType </entity type> <context> The Company applies a more-likely-than-not threshold for financial statement recognition and measurement of an uncertain tax position taken or expected to be taken in a tax return. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. As of December 31, 2024 and 2023, the Company has reserved approximately $ 14,626 and $ 13,631 , respectively, for uncertain tax positions, including interest and penalties, which is classified within accrued liabilities on the accompanying consolidated balance sheet. </context> | us-gaap:LiabilityForUncertainTaxPositionsCurrent |
The Company’s receivables represent unconditional rights to consideration from our Services Agreements with our university partners. Accounts receivable, net is stated at net realizable value and contains billed and unbilled revenue. The Company utilizes the allowance method to provide for doubtful accounts based on its evaluation of the collectability of the amounts due. There have been no amounts written off and no reserves established as of December 31, 2024 given historical collection experience and an evaluation of reasonable and supportable forecasts of economic conditions and other pertinent factors affecting the Company’s customers such as known credit risk or industry trends. The Company will continue to review and revise its allowance methodology based on its collection experience with its partners. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> The Company’s receivables represent unconditional rights to consideration from our Services Agreements with our university partners. Accounts receivable, net is stated at net realizable value and contains billed and unbilled revenue. The Company utilizes the allowance method to provide for doubtful accounts based on its evaluation of the collectability of the amounts due. There have been no amounts written off and no reserves established as of December 31, 2024 given historical collection experience and an evaluation of reasonable and supportable forecasts of economic conditions and other pertinent factors affecting the Company’s customers such as known credit risk or industry trends. The Company will continue to review and revise its allowance methodology based on its collection experience with its partners. </context> | us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs |
The Company’s receivables represent unconditional rights to consideration from our Services Agreements with our university partners. Accounts receivable, net is stated at net realizable value and contains billed and unbilled revenue. The Company utilizes the allowance method to provide for doubtful accounts based on its evaluation of the collectability of the amounts due. There have been no amounts written off and no reserves established as of December 31, 2024 given historical collection experience and an evaluation of reasonable and supportable forecasts of economic conditions and other pertinent factors affecting the Company’s customers such as known credit risk or industry trends. The Company will continue to review and revise its allowance methodology based on its collection experience with its partners. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> The Company’s receivables represent unconditional rights to consideration from our Services Agreements with our university partners. Accounts receivable, net is stated at net realizable value and contains billed and unbilled revenue. The Company utilizes the allowance method to provide for doubtful accounts based on its evaluation of the collectability of the amounts due. There have been no amounts written off and no reserves established as of December 31, 2024 given historical collection experience and an evaluation of reasonable and supportable forecasts of economic conditions and other pertinent factors affecting the Company’s customers such as known credit risk or industry trends. The Company will continue to review and revise its allowance methodology based on its collection experience with its partners. </context> | us-gaap:AllowanceForDoubtfulAccountsReceivable |
For our partners with unbilled revenue, revenue recognition occurs in advance of billings. Billings for some university partners do not occur until after the service period has commenced and final enrollment information is available. Our unbilled revenue of $ 115 and $ 188 as of December 31, 2024 and 2023, respectively, are included in accounts receivable in our consolidated balance sheets. Deferred revenue represents the excess of amounts received as compared to amounts recognized in revenue on our consolidated statements of income as of the end of the reporting period, and such amounts are reflected as a current liability on our consolidated balance sheets. We generally receive payments for our services billed within 30 days of invoice. These payments are recorded as deferred revenue until the services are delivered and revenue is recognized. | text | 115 | monetaryItemType | text: <entity> 115 </entity> <entity type> monetaryItemType </entity type> <context> For our partners with unbilled revenue, revenue recognition occurs in advance of billings. Billings for some university partners do not occur until after the service period has commenced and final enrollment information is available. Our unbilled revenue of $ 115 and $ 188 as of December 31, 2024 and 2023, respectively, are included in accounts receivable in our consolidated balance sheets. Deferred revenue represents the excess of amounts received as compared to amounts recognized in revenue on our consolidated statements of income as of the end of the reporting period, and such amounts are reflected as a current liability on our consolidated balance sheets. We generally receive payments for our services billed within 30 days of invoice. These payments are recorded as deferred revenue until the services are delivered and revenue is recognized. </context> | us-gaap:UnbilledReceivablesCurrent |
For our partners with unbilled revenue, revenue recognition occurs in advance of billings. Billings for some university partners do not occur until after the service period has commenced and final enrollment information is available. Our unbilled revenue of $ 115 and $ 188 as of December 31, 2024 and 2023, respectively, are included in accounts receivable in our consolidated balance sheets. Deferred revenue represents the excess of amounts received as compared to amounts recognized in revenue on our consolidated statements of income as of the end of the reporting period, and such amounts are reflected as a current liability on our consolidated balance sheets. We generally receive payments for our services billed within 30 days of invoice. These payments are recorded as deferred revenue until the services are delivered and revenue is recognized. | text | 188 | monetaryItemType | text: <entity> 188 </entity> <entity type> monetaryItemType </entity type> <context> For our partners with unbilled revenue, revenue recognition occurs in advance of billings. Billings for some university partners do not occur until after the service period has commenced and final enrollment information is available. Our unbilled revenue of $ 115 and $ 188 as of December 31, 2024 and 2023, respectively, are included in accounts receivable in our consolidated balance sheets. Deferred revenue represents the excess of amounts received as compared to amounts recognized in revenue on our consolidated statements of income as of the end of the reporting period, and such amounts are reflected as a current liability on our consolidated balance sheets. We generally receive payments for our services billed within 30 days of invoice. These payments are recorded as deferred revenue until the services are delivered and revenue is recognized. </context> | us-gaap:UnbilledReceivablesCurrent |
The Company believes the credit risk related to cash equivalents and investments is limited due to its adherence to an investment policy that required investments to have a minimum BBB rating, depending on the type of security, by one major rating agency at the time of purchase. All of the Company’s cash equivalents and investments as of December 31, 2024 and 2023 consist of investments rated BBB or higher by at least one rating agency. Additionally, the Company utilizes at least one financial institution to conduct initial and ongoing credit analysis on its investment portfolio to monitor and lower the potential impact of market risk associated with its cash equivalents and investment portfolio. Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, which are primarily invested in money market funds or on deposit at high credit quality financial institutions in the U.S. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At December 31, 2024 and December 31, 2023, the Company had $ 323,124 and $ 145,474 , respectively, in excess of the FDIC insured limit . The Company is also subject to credit risk for its accounts receivable balance. The Company has not experienced any losses on accounts receivables since July 1, 2018, the date the Company transitioned to an education service company. To manage accounts receivable risk, the Company maintains an allowance for doubtful accounts, if needed. Our dependence on our most significant university partner, with 88.9 % and 87.8 % of total service revenue for the years ended December 31, 2024 and 2023, respectively, subjects us to the risk that declines in our customer’s operations would result in a sustained reduction in service revenue for the Company. | text | 323124 | monetaryItemType | text: <entity> 323124 </entity> <entity type> monetaryItemType </entity type> <context> The Company believes the credit risk related to cash equivalents and investments is limited due to its adherence to an investment policy that required investments to have a minimum BBB rating, depending on the type of security, by one major rating agency at the time of purchase. All of the Company’s cash equivalents and investments as of December 31, 2024 and 2023 consist of investments rated BBB or higher by at least one rating agency. Additionally, the Company utilizes at least one financial institution to conduct initial and ongoing credit analysis on its investment portfolio to monitor and lower the potential impact of market risk associated with its cash equivalents and investment portfolio. Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, which are primarily invested in money market funds or on deposit at high credit quality financial institutions in the U.S. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At December 31, 2024 and December 31, 2023, the Company had $ 323,124 and $ 145,474 , respectively, in excess of the FDIC insured limit . The Company is also subject to credit risk for its accounts receivable balance. The Company has not experienced any losses on accounts receivables since July 1, 2018, the date the Company transitioned to an education service company. To manage accounts receivable risk, the Company maintains an allowance for doubtful accounts, if needed. Our dependence on our most significant university partner, with 88.9 % and 87.8 % of total service revenue for the years ended December 31, 2024 and 2023, respectively, subjects us to the risk that declines in our customer’s operations would result in a sustained reduction in service revenue for the Company. </context> | us-gaap:CashUninsuredAmount |
The Company believes the credit risk related to cash equivalents and investments is limited due to its adherence to an investment policy that required investments to have a minimum BBB rating, depending on the type of security, by one major rating agency at the time of purchase. All of the Company’s cash equivalents and investments as of December 31, 2024 and 2023 consist of investments rated BBB or higher by at least one rating agency. Additionally, the Company utilizes at least one financial institution to conduct initial and ongoing credit analysis on its investment portfolio to monitor and lower the potential impact of market risk associated with its cash equivalents and investment portfolio. Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, which are primarily invested in money market funds or on deposit at high credit quality financial institutions in the U.S. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At December 31, 2024 and December 31, 2023, the Company had $ 323,124 and $ 145,474 , respectively, in excess of the FDIC insured limit . The Company is also subject to credit risk for its accounts receivable balance. The Company has not experienced any losses on accounts receivables since July 1, 2018, the date the Company transitioned to an education service company. To manage accounts receivable risk, the Company maintains an allowance for doubtful accounts, if needed. Our dependence on our most significant university partner, with 88.9 % and 87.8 % of total service revenue for the years ended December 31, 2024 and 2023, respectively, subjects us to the risk that declines in our customer’s operations would result in a sustained reduction in service revenue for the Company. | text | 145474 | monetaryItemType | text: <entity> 145474 </entity> <entity type> monetaryItemType </entity type> <context> The Company believes the credit risk related to cash equivalents and investments is limited due to its adherence to an investment policy that required investments to have a minimum BBB rating, depending on the type of security, by one major rating agency at the time of purchase. All of the Company’s cash equivalents and investments as of December 31, 2024 and 2023 consist of investments rated BBB or higher by at least one rating agency. Additionally, the Company utilizes at least one financial institution to conduct initial and ongoing credit analysis on its investment portfolio to monitor and lower the potential impact of market risk associated with its cash equivalents and investment portfolio. Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, which are primarily invested in money market funds or on deposit at high credit quality financial institutions in the U.S. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At December 31, 2024 and December 31, 2023, the Company had $ 323,124 and $ 145,474 , respectively, in excess of the FDIC insured limit . The Company is also subject to credit risk for its accounts receivable balance. The Company has not experienced any losses on accounts receivables since July 1, 2018, the date the Company transitioned to an education service company. To manage accounts receivable risk, the Company maintains an allowance for doubtful accounts, if needed. Our dependence on our most significant university partner, with 88.9 % and 87.8 % of total service revenue for the years ended December 31, 2024 and 2023, respectively, subjects us to the risk that declines in our customer’s operations would result in a sustained reduction in service revenue for the Company. </context> | us-gaap:CashUninsuredAmount |
The Company believes the credit risk related to cash equivalents and investments is limited due to its adherence to an investment policy that required investments to have a minimum BBB rating, depending on the type of security, by one major rating agency at the time of purchase. All of the Company’s cash equivalents and investments as of December 31, 2024 and 2023 consist of investments rated BBB or higher by at least one rating agency. Additionally, the Company utilizes at least one financial institution to conduct initial and ongoing credit analysis on its investment portfolio to monitor and lower the potential impact of market risk associated with its cash equivalents and investment portfolio. Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, which are primarily invested in money market funds or on deposit at high credit quality financial institutions in the U.S. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At December 31, 2024 and December 31, 2023, the Company had $ 323,124 and $ 145,474 , respectively, in excess of the FDIC insured limit . The Company is also subject to credit risk for its accounts receivable balance. The Company has not experienced any losses on accounts receivables since July 1, 2018, the date the Company transitioned to an education service company. To manage accounts receivable risk, the Company maintains an allowance for doubtful accounts, if needed. Our dependence on our most significant university partner, with 88.9 % and 87.8 % of total service revenue for the years ended December 31, 2024 and 2023, respectively, subjects us to the risk that declines in our customer’s operations would result in a sustained reduction in service revenue for the Company. | text | 88.9 | percentItemType | text: <entity> 88.9 </entity> <entity type> percentItemType </entity type> <context> The Company believes the credit risk related to cash equivalents and investments is limited due to its adherence to an investment policy that required investments to have a minimum BBB rating, depending on the type of security, by one major rating agency at the time of purchase. All of the Company’s cash equivalents and investments as of December 31, 2024 and 2023 consist of investments rated BBB or higher by at least one rating agency. Additionally, the Company utilizes at least one financial institution to conduct initial and ongoing credit analysis on its investment portfolio to monitor and lower the potential impact of market risk associated with its cash equivalents and investment portfolio. Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, which are primarily invested in money market funds or on deposit at high credit quality financial institutions in the U.S. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At December 31, 2024 and December 31, 2023, the Company had $ 323,124 and $ 145,474 , respectively, in excess of the FDIC insured limit . The Company is also subject to credit risk for its accounts receivable balance. The Company has not experienced any losses on accounts receivables since July 1, 2018, the date the Company transitioned to an education service company. To manage accounts receivable risk, the Company maintains an allowance for doubtful accounts, if needed. Our dependence on our most significant university partner, with 88.9 % and 87.8 % of total service revenue for the years ended December 31, 2024 and 2023, respectively, subjects us to the risk that declines in our customer’s operations would result in a sustained reduction in service revenue for the Company. </context> | us-gaap:ConcentrationRiskPercentage1 |
The Company believes the credit risk related to cash equivalents and investments is limited due to its adherence to an investment policy that required investments to have a minimum BBB rating, depending on the type of security, by one major rating agency at the time of purchase. All of the Company’s cash equivalents and investments as of December 31, 2024 and 2023 consist of investments rated BBB or higher by at least one rating agency. Additionally, the Company utilizes at least one financial institution to conduct initial and ongoing credit analysis on its investment portfolio to monitor and lower the potential impact of market risk associated with its cash equivalents and investment portfolio. Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, which are primarily invested in money market funds or on deposit at high credit quality financial institutions in the U.S. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At December 31, 2024 and December 31, 2023, the Company had $ 323,124 and $ 145,474 , respectively, in excess of the FDIC insured limit . The Company is also subject to credit risk for its accounts receivable balance. The Company has not experienced any losses on accounts receivables since July 1, 2018, the date the Company transitioned to an education service company. To manage accounts receivable risk, the Company maintains an allowance for doubtful accounts, if needed. Our dependence on our most significant university partner, with 88.9 % and 87.8 % of total service revenue for the years ended December 31, 2024 and 2023, respectively, subjects us to the risk that declines in our customer’s operations would result in a sustained reduction in service revenue for the Company. | text | 87.8 | percentItemType | text: <entity> 87.8 </entity> <entity type> percentItemType </entity type> <context> The Company believes the credit risk related to cash equivalents and investments is limited due to its adherence to an investment policy that required investments to have a minimum BBB rating, depending on the type of security, by one major rating agency at the time of purchase. All of the Company’s cash equivalents and investments as of December 31, 2024 and 2023 consist of investments rated BBB or higher by at least one rating agency. Additionally, the Company utilizes at least one financial institution to conduct initial and ongoing credit analysis on its investment portfolio to monitor and lower the potential impact of market risk associated with its cash equivalents and investment portfolio. Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, which are primarily invested in money market funds or on deposit at high credit quality financial institutions in the U.S. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At December 31, 2024 and December 31, 2023, the Company had $ 323,124 and $ 145,474 , respectively, in excess of the FDIC insured limit . The Company is also subject to credit risk for its accounts receivable balance. The Company has not experienced any losses on accounts receivables since July 1, 2018, the date the Company transitioned to an education service company. To manage accounts receivable risk, the Company maintains an allowance for doubtful accounts, if needed. Our dependence on our most significant university partner, with 88.9 % and 87.8 % of total service revenue for the years ended December 31, 2024 and 2023, respectively, subjects us to the risk that declines in our customer’s operations would result in a sustained reduction in service revenue for the Company. </context> | us-gaap:ConcentrationRiskPercentage1 |
As of December 31, 2024 and 2023, the Company had investments of $ 0 and $ 98,031 , respectively, classified as available-for sale securities. The Company sold all its investments in the third quarter of 2024 and the proceeds were invested in cash and cash equivalents. | text | 0 | monetaryItemType | text: <entity> 0 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had investments of $ 0 and $ 98,031 , respectively, classified as available-for sale securities. The Company sold all its investments in the third quarter of 2024 and the proceeds were invested in cash and cash equivalents. </context> | us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent |
As of December 31, 2024 and 2023, the Company had investments of $ 0 and $ 98,031 , respectively, classified as available-for sale securities. The Company sold all its investments in the third quarter of 2024 and the proceeds were invested in cash and cash equivalents. | text | 98031 | monetaryItemType | text: <entity> 98031 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had investments of $ 0 and $ 98,031 , respectively, classified as available-for sale securities. The Company sold all its investments in the third quarter of 2024 and the proceeds were invested in cash and cash equivalents. </context> | us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent |
For the year ended December 31, 2024, the net realized gains were $ 57 and for the years ended December 31, 2023 and 2022, unrealized gains and losses were $ 476 and $ 533 , respectively, net of taxes. Available-for-sale securities are carried at fair value on the consolidated balance sheets. The Company estimates the lifetime expected credit losses for all available-for-sale debt securities in an unrealized loss position. If our assessment indicates that an expected credit loss exists, we determine the portion of the unrealized loss attributable to credit deterioration and record a reserve for the expected credit loss in the allowance for credit losses in technology and academic services in our consolidated income statements. | text | 57 | monetaryItemType | text: <entity> 57 </entity> <entity type> monetaryItemType </entity type> <context> For the year ended December 31, 2024, the net realized gains were $ 57 and for the years ended December 31, 2023 and 2022, unrealized gains and losses were $ 476 and $ 533 , respectively, net of taxes. Available-for-sale securities are carried at fair value on the consolidated balance sheets. The Company estimates the lifetime expected credit losses for all available-for-sale debt securities in an unrealized loss position. If our assessment indicates that an expected credit loss exists, we determine the portion of the unrealized loss attributable to credit deterioration and record a reserve for the expected credit loss in the allowance for credit losses in technology and academic services in our consolidated income statements. </context> | us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss |
For the year ended December 31, 2024, the net realized gains were $ 57 and for the years ended December 31, 2023 and 2022, unrealized gains and losses were $ 476 and $ 533 , respectively, net of taxes. Available-for-sale securities are carried at fair value on the consolidated balance sheets. The Company estimates the lifetime expected credit losses for all available-for-sale debt securities in an unrealized loss position. If our assessment indicates that an expected credit loss exists, we determine the portion of the unrealized loss attributable to credit deterioration and record a reserve for the expected credit loss in the allowance for credit losses in technology and academic services in our consolidated income statements. | text | 476 | monetaryItemType | text: <entity> 476 </entity> <entity type> monetaryItemType </entity type> <context> For the year ended December 31, 2024, the net realized gains were $ 57 and for the years ended December 31, 2023 and 2022, unrealized gains and losses were $ 476 and $ 533 , respectively, net of taxes. Available-for-sale securities are carried at fair value on the consolidated balance sheets. The Company estimates the lifetime expected credit losses for all available-for-sale debt securities in an unrealized loss position. If our assessment indicates that an expected credit loss exists, we determine the portion of the unrealized loss attributable to credit deterioration and record a reserve for the expected credit loss in the allowance for credit losses in technology and academic services in our consolidated income statements. </context> | us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss |
For the year ended December 31, 2024, the net realized gains were $ 57 and for the years ended December 31, 2023 and 2022, unrealized gains and losses were $ 476 and $ 533 , respectively, net of taxes. Available-for-sale securities are carried at fair value on the consolidated balance sheets. The Company estimates the lifetime expected credit losses for all available-for-sale debt securities in an unrealized loss position. If our assessment indicates that an expected credit loss exists, we determine the portion of the unrealized loss attributable to credit deterioration and record a reserve for the expected credit loss in the allowance for credit losses in technology and academic services in our consolidated income statements. | text | 533 | monetaryItemType | text: <entity> 533 </entity> <entity type> monetaryItemType </entity type> <context> For the year ended December 31, 2024, the net realized gains were $ 57 and for the years ended December 31, 2023 and 2022, unrealized gains and losses were $ 476 and $ 533 , respectively, net of taxes. Available-for-sale securities are carried at fair value on the consolidated balance sheets. The Company estimates the lifetime expected credit losses for all available-for-sale debt securities in an unrealized loss position. If our assessment indicates that an expected credit loss exists, we determine the portion of the unrealized loss attributable to credit deterioration and record a reserve for the expected credit loss in the allowance for credit losses in technology and academic services in our consolidated income statements. </context> | us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss |
Depreciation expense associated with property and equipment totaled $ 27,760 , $ 23,106 and $ 22,115 for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 27760 | monetaryItemType | text: <entity> 27760 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense associated with property and equipment totaled $ 27,760 , $ 23,106 and $ 22,115 for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:DepreciationDepletionAndAmortization |
Depreciation expense associated with property and equipment totaled $ 27,760 , $ 23,106 and $ 22,115 for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 23106 | monetaryItemType | text: <entity> 23106 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense associated with property and equipment totaled $ 27,760 , $ 23,106 and $ 22,115 for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:DepreciationDepletionAndAmortization |
Depreciation expense associated with property and equipment totaled $ 27,760 , $ 23,106 and $ 22,115 for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 22115 | monetaryItemType | text: <entity> 22115 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense associated with property and equipment totaled $ 27,760 , $ 23,106 and $ 22,115 for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:DepreciationDepletionAndAmortization |
Identified intangible assets of $ 210,280 consisted primarily of university partner relationships that were valued at $ 210,000 , which arose in connection with the acquisition of Orbis Education in January 2019. | text | 210280 | monetaryItemType | text: <entity> 210280 </entity> <entity type> monetaryItemType </entity type> <context> Identified intangible assets of $ 210,280 consisted primarily of university partner relationships that were valued at $ 210,000 , which arose in connection with the acquisition of Orbis Education in January 2019. </context> | us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill |
Identified intangible assets of $ 210,280 consisted primarily of university partner relationships that were valued at $ 210,000 , which arose in connection with the acquisition of Orbis Education in January 2019. | text | 210000 | monetaryItemType | text: <entity> 210000 </entity> <entity type> monetaryItemType </entity type> <context> Identified intangible assets of $ 210,280 consisted primarily of university partner relationships that were valued at $ 210,000 , which arose in connection with the acquisition of Orbis Education in January 2019. </context> | us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill |
The Company has operating leases for off-campus classroom and laboratory site locations, office space, office equipment, and optical fiber communication lines. These leases have terms that range from one month to ten years and four months. At lease inception, we determine the lease term by assuming no exercises of renewal options, due to the Company’s constantly changing geographical needs for its university partners. Leases with an initial term of 12 months or less are not recorded in the consolidated balance sheets and we recognize lease expense for these leases on a straight-line basis over the lease term. The Company has operating lease costs of $ 16,694 , $ 13,496 and $ 10,666 for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 16694 | monetaryItemType | text: <entity> 16694 </entity> <entity type> monetaryItemType </entity type> <context> The Company has operating leases for off-campus classroom and laboratory site locations, office space, office equipment, and optical fiber communication lines. These leases have terms that range from one month to ten years and four months. At lease inception, we determine the lease term by assuming no exercises of renewal options, due to the Company’s constantly changing geographical needs for its university partners. Leases with an initial term of 12 months or less are not recorded in the consolidated balance sheets and we recognize lease expense for these leases on a straight-line basis over the lease term. The Company has operating lease costs of $ 16,694 , $ 13,496 and $ 10,666 for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:OperatingLeaseCost |
The Company has operating leases for off-campus classroom and laboratory site locations, office space, office equipment, and optical fiber communication lines. These leases have terms that range from one month to ten years and four months. At lease inception, we determine the lease term by assuming no exercises of renewal options, due to the Company’s constantly changing geographical needs for its university partners. Leases with an initial term of 12 months or less are not recorded in the consolidated balance sheets and we recognize lease expense for these leases on a straight-line basis over the lease term. The Company has operating lease costs of $ 16,694 , $ 13,496 and $ 10,666 for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 13496 | monetaryItemType | text: <entity> 13496 </entity> <entity type> monetaryItemType </entity type> <context> The Company has operating leases for off-campus classroom and laboratory site locations, office space, office equipment, and optical fiber communication lines. These leases have terms that range from one month to ten years and four months. At lease inception, we determine the lease term by assuming no exercises of renewal options, due to the Company’s constantly changing geographical needs for its university partners. Leases with an initial term of 12 months or less are not recorded in the consolidated balance sheets and we recognize lease expense for these leases on a straight-line basis over the lease term. The Company has operating lease costs of $ 16,694 , $ 13,496 and $ 10,666 for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:OperatingLeaseCost |
The Company has operating leases for off-campus classroom and laboratory site locations, office space, office equipment, and optical fiber communication lines. These leases have terms that range from one month to ten years and four months. At lease inception, we determine the lease term by assuming no exercises of renewal options, due to the Company’s constantly changing geographical needs for its university partners. Leases with an initial term of 12 months or less are not recorded in the consolidated balance sheets and we recognize lease expense for these leases on a straight-line basis over the lease term. The Company has operating lease costs of $ 16,694 , $ 13,496 and $ 10,666 for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 10666 | monetaryItemType | text: <entity> 10666 </entity> <entity type> monetaryItemType </entity type> <context> The Company has operating leases for off-campus classroom and laboratory site locations, office space, office equipment, and optical fiber communication lines. These leases have terms that range from one month to ten years and four months. At lease inception, we determine the lease term by assuming no exercises of renewal options, due to the Company’s constantly changing geographical needs for its university partners. Leases with an initial term of 12 months or less are not recorded in the consolidated balance sheets and we recognize lease expense for these leases on a straight-line basis over the lease term. The Company has operating lease costs of $ 16,694 , $ 13,496 and $ 10,666 for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:OperatingLeaseCost |
As of December 31, 2024, the Company had $ 17,029 of non-cancelable operating lease commitments for four off-campus classroom and laboratory sites that had not yet commenced. The Company’s weighted-average remaining lease term relating to its operating leases is 7.62 years, with a weighted-average discount rate of 4.22 % . The cash paid | text | 17029 | monetaryItemType | text: <entity> 17029 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had $ 17,029 of non-cancelable operating lease commitments for four off-campus classroom and laboratory sites that had not yet commenced. The Company’s weighted-average remaining lease term relating to its operating leases is 7.62 years, with a weighted-average discount rate of 4.22 % . The cash paid </context> | us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount |
As of December 31, 2024, the Company had $ 17,029 of non-cancelable operating lease commitments for four off-campus classroom and laboratory sites that had not yet commenced. The Company’s weighted-average remaining lease term relating to its operating leases is 7.62 years, with a weighted-average discount rate of 4.22 % . The cash paid | text | 4.22 | percentItemType | text: <entity> 4.22 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2024, the Company had $ 17,029 of non-cancelable operating lease commitments for four off-campus classroom and laboratory sites that had not yet commenced. The Company’s weighted-average remaining lease term relating to its operating leases is 7.62 years, with a weighted-average discount rate of 4.22 % . The cash paid </context> | us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent |
for operating lease liabilities was $ 14,895 , $ 11,391 and $ 9,537 for the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, the Company had no financing leases. | text | 14895 | monetaryItemType | text: <entity> 14895 </entity> <entity type> monetaryItemType </entity type> <context> for operating lease liabilities was $ 14,895 , $ 11,391 and $ 9,537 for the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, the Company had no financing leases. </context> | us-gaap:OperatingLeasePayments |
for operating lease liabilities was $ 14,895 , $ 11,391 and $ 9,537 for the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, the Company had no financing leases. | text | 11391 | monetaryItemType | text: <entity> 11391 </entity> <entity type> monetaryItemType </entity type> <context> for operating lease liabilities was $ 14,895 , $ 11,391 and $ 9,537 for the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, the Company had no financing leases. </context> | us-gaap:OperatingLeasePayments |
for operating lease liabilities was $ 14,895 , $ 11,391 and $ 9,537 for the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, the Company had no financing leases. | text | 9537 | monetaryItemType | text: <entity> 9537 </entity> <entity type> monetaryItemType </entity type> <context> for operating lease liabilities was $ 14,895 , $ 11,391 and $ 9,537 for the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, the Company had no financing leases. </context> | us-gaap:OperatingLeasePayments |
Diluted weighted average shares outstanding excludes the incremental effect of unvested restricted stock and shares that would be issued upon the assumed exercise of stock options in accordance with the treasury stock method. For each of the years ended December 31, 2024, 2023 and 2022, approximately 20 , 52 , and 58 , respectively, of the Company’s restricted stock awards outstanding were excluded from the calculation of diluted earnings per share as their inclusion would have been anti-dilutive. These restricted stock awards could be dilutive in the future. | text | 20 | sharesItemType | text: <entity> 20 </entity> <entity type> sharesItemType </entity type> <context> Diluted weighted average shares outstanding excludes the incremental effect of unvested restricted stock and shares that would be issued upon the assumed exercise of stock options in accordance with the treasury stock method. For each of the years ended December 31, 2024, 2023 and 2022, approximately 20 , 52 , and 58 , respectively, of the Company’s restricted stock awards outstanding were excluded from the calculation of diluted earnings per share as their inclusion would have been anti-dilutive. These restricted stock awards could be dilutive in the future. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Diluted weighted average shares outstanding excludes the incremental effect of unvested restricted stock and shares that would be issued upon the assumed exercise of stock options in accordance with the treasury stock method. For each of the years ended December 31, 2024, 2023 and 2022, approximately 20 , 52 , and 58 , respectively, of the Company’s restricted stock awards outstanding were excluded from the calculation of diluted earnings per share as their inclusion would have been anti-dilutive. These restricted stock awards could be dilutive in the future. | text | 52 | sharesItemType | text: <entity> 52 </entity> <entity type> sharesItemType </entity type> <context> Diluted weighted average shares outstanding excludes the incremental effect of unvested restricted stock and shares that would be issued upon the assumed exercise of stock options in accordance with the treasury stock method. For each of the years ended December 31, 2024, 2023 and 2022, approximately 20 , 52 , and 58 , respectively, of the Company’s restricted stock awards outstanding were excluded from the calculation of diluted earnings per share as their inclusion would have been anti-dilutive. These restricted stock awards could be dilutive in the future. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Diluted weighted average shares outstanding excludes the incremental effect of unvested restricted stock and shares that would be issued upon the assumed exercise of stock options in accordance with the treasury stock method. For each of the years ended December 31, 2024, 2023 and 2022, approximately 20 , 52 , and 58 , respectively, of the Company’s restricted stock awards outstanding were excluded from the calculation of diluted earnings per share as their inclusion would have been anti-dilutive. These restricted stock awards could be dilutive in the future. | text | 58 | sharesItemType | text: <entity> 58 </entity> <entity type> sharesItemType </entity type> <context> Diluted weighted average shares outstanding excludes the incremental effect of unvested restricted stock and shares that would be issued upon the assumed exercise of stock options in accordance with the treasury stock method. For each of the years ended December 31, 2024, 2023 and 2022, approximately 20 , 52 , and 58 , respectively, of the Company’s restricted stock awards outstanding were excluded from the calculation of diluted earnings per share as their inclusion would have been anti-dilutive. These restricted stock awards could be dilutive in the future. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
During the year ended December 31, 2024, the Company repurchased 1,142 shares of common stock at an aggregate cost of $ 165,405 . As of December 31, 2024, there remained $ 99,648 available under its current share | text | 1142 | sharesItemType | text: <entity> 1142 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2024, the Company repurchased 1,142 shares of common stock at an aggregate cost of $ 165,405 . As of December 31, 2024, there remained $ 99,648 available under its current share </context> | us-gaap:TreasuryStockSharesAcquired |
During the year ended December 31, 2024, the Company repurchased 1,142 shares of common stock at an aggregate cost of $ 165,405 . As of December 31, 2024, there remained $ 99,648 available under its current share | text | 165405 | monetaryItemType | text: <entity> 165405 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Company repurchased 1,142 shares of common stock at an aggregate cost of $ 165,405 . As of December 31, 2024, there remained $ 99,648 available under its current share </context> | us-gaap:TreasuryStockValueAcquiredCostMethod |
During the year ended December 31, 2024, the Company repurchased 1,142 shares of common stock at an aggregate cost of $ 165,405 . As of December 31, 2024, there remained $ 99,648 available under its current share | text | 99648 | monetaryItemType | text: <entity> 99648 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Company repurchased 1,142 shares of common stock at an aggregate cost of $ 165,405 . As of December 31, 2024, there remained $ 99,648 available under its current share </context> | us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 |
The Company recognizes the impact of a tax position in its financial statements if that position is more-likely-than-not to be sustained on audit, based on the technical merits of the position. The Company discloses all unrecognized tax benefits, which includes the reserves recorded for uncertain tax positions on filed tax returns and the unrecognized portion of affirmative claims. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. Unrecognized tax benefits as of December 31, 2024 and 2023 were $ 14,626 and $ 13,631 , respectively. | text | 14626 | monetaryItemType | text: <entity> 14626 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognizes the impact of a tax position in its financial statements if that position is more-likely-than-not to be sustained on audit, based on the technical merits of the position. The Company discloses all unrecognized tax benefits, which includes the reserves recorded for uncertain tax positions on filed tax returns and the unrecognized portion of affirmative claims. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. Unrecognized tax benefits as of December 31, 2024 and 2023 were $ 14,626 and $ 13,631 , respectively. </context> | us-gaap:UnrecognizedTaxBenefits |
The Company recognizes the impact of a tax position in its financial statements if that position is more-likely-than-not to be sustained on audit, based on the technical merits of the position. The Company discloses all unrecognized tax benefits, which includes the reserves recorded for uncertain tax positions on filed tax returns and the unrecognized portion of affirmative claims. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. Unrecognized tax benefits as of December 31, 2024 and 2023 were $ 14,626 and $ 13,631 , respectively. | text | 13631 | monetaryItemType | text: <entity> 13631 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognizes the impact of a tax position in its financial statements if that position is more-likely-than-not to be sustained on audit, based on the technical merits of the position. The Company discloses all unrecognized tax benefits, which includes the reserves recorded for uncertain tax positions on filed tax returns and the unrecognized portion of affirmative claims. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. Unrecognized tax benefits as of December 31, 2024 and 2023 were $ 14,626 and $ 13,631 , respectively. </context> | us-gaap:UnrecognizedTaxBenefits |
As of December 31, 2024 and 2023, the unrecognized tax benefit recorded of $ 14,626 and $ 13,631 , respectively, if reversed, would impact the effective tax rate. At both years ended December 31, 2024 and 2023 the Company had accrued $ 0 , in interest and $ 0 , in penalties. It is reasonably possible that the amount of the unrecognized tax benefit will change during the next 12 months, however management does not expect the potential change to have a material effect on the results of operations or financial position. | text | 14626 | monetaryItemType | text: <entity> 14626 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the unrecognized tax benefit recorded of $ 14,626 and $ 13,631 , respectively, if reversed, would impact the effective tax rate. At both years ended December 31, 2024 and 2023 the Company had accrued $ 0 , in interest and $ 0 , in penalties. It is reasonably possible that the amount of the unrecognized tax benefit will change during the next 12 months, however management does not expect the potential change to have a material effect on the results of operations or financial position. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
As of December 31, 2024 and 2023, the unrecognized tax benefit recorded of $ 14,626 and $ 13,631 , respectively, if reversed, would impact the effective tax rate. At both years ended December 31, 2024 and 2023 the Company had accrued $ 0 , in interest and $ 0 , in penalties. It is reasonably possible that the amount of the unrecognized tax benefit will change during the next 12 months, however management does not expect the potential change to have a material effect on the results of operations or financial position. | text | 13631 | monetaryItemType | text: <entity> 13631 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the unrecognized tax benefit recorded of $ 14,626 and $ 13,631 , respectively, if reversed, would impact the effective tax rate. At both years ended December 31, 2024 and 2023 the Company had accrued $ 0 , in interest and $ 0 , in penalties. It is reasonably possible that the amount of the unrecognized tax benefit will change during the next 12 months, however management does not expect the potential change to have a material effect on the results of operations or financial position. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
The Company makes equity incentive grants pursuant to our 2017 Equity Incentive Plan (the “2017 Plan”) under which a maximum of 3,000 shares may be granted. As of December 31, 2024, 962 shares were available for grants under the 2017 Plan. | text | 3000 | sharesItemType | text: <entity> 3000 </entity> <entity type> sharesItemType </entity type> <context> The Company makes equity incentive grants pursuant to our 2017 Equity Incentive Plan (the “2017 Plan”) under which a maximum of 3,000 shares may be granted. As of December 31, 2024, 962 shares were available for grants under the 2017 Plan. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
The Company makes equity incentive grants pursuant to our 2017 Equity Incentive Plan (the “2017 Plan”) under which a maximum of 3,000 shares may be granted. As of December 31, 2024, 962 shares were available for grants under the 2017 Plan. | text | 962 | sharesItemType | text: <entity> 962 </entity> <entity type> sharesItemType </entity type> <context> The Company makes equity incentive grants pursuant to our 2017 Equity Incentive Plan (the “2017 Plan”) under which a maximum of 3,000 shares may be granted. As of December 31, 2024, 962 shares were available for grants under the 2017 Plan. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. | text | 117 | sharesItemType | text: <entity> 117 </entity> <entity type> sharesItemType </entity type> <context> During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. | text | 136 | sharesItemType | text: <entity> 136 </entity> <entity type> sharesItemType </entity type> <context> During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. | text | 189 | sharesItemType | text: <entity> 189 </entity> <entity type> sharesItemType </entity type> <context> During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. | text | 20 | percentItemType | text: <entity> 20 </entity> <entity type> percentItemType </entity type> <context> During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. | text | 55 | sharesItemType | text: <entity> 55 </entity> <entity type> sharesItemType </entity type> <context> During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. </context> | us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation |
During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. | text | 56 | sharesItemType | text: <entity> 56 </entity> <entity type> sharesItemType </entity type> <context> During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. </context> | us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation |
During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. | text | 52 | sharesItemType | text: <entity> 52 </entity> <entity type> sharesItemType </entity type> <context> During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. </context> | us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation |
During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. | text | 7446 | monetaryItemType | text: <entity> 7446 </entity> <entity type> monetaryItemType </entity type> <context> During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. </context> | us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation |
During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. | text | 6331 | monetaryItemType | text: <entity> 6331 </entity> <entity type> monetaryItemType </entity type> <context> During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. </context> | us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation |
During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. | text | 4625 | monetaryItemType | text: <entity> 4625 </entity> <entity type> monetaryItemType </entity type> <context> During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. </context> | us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation |
During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. | text | 3 | sharesItemType | text: <entity> 3 </entity> <entity type> sharesItemType </entity type> <context> During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. | text | 4 | sharesItemType | text: <entity> 4 </entity> <entity type> sharesItemType </entity type> <context> During fiscal years 2024, 2023, and 2022, the Company granted 117 , 136 , and 189 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20 % over each of the next five years . Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2024, 2023 and 2022, the Company withheld 55 , 56 , and 52 shares of common stock in lieu of taxes at a cost of $ 7,446 , $ 6,331 , and $ 4,625 , on the restricted stock vesting dates, respectively. In April 2024, a new non-employee director was appointed to the Board of Directors and was granted an initial award of shares pursuant to the Company’s compensation program. The initial award of shares that were granted to such newly appointed director have voting rights and vest on the one-year anniversary of the date of grant. During 2024, 2023 and 2022, following the annual stockholders meeting, the Company granted 3 , 4 and 4 shares of common stock to the non-employee members of the Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
On June 30, 2024, a named executive officer resigned for “good reason” which, under the terms of his employment agreement, resulted in an acceleration of the vesting of the next tranche of five outstanding restricted stock awards that would have otherwise vested on March 1, 2025. As a result, the incremental share-based compensation expense from the modification on the five restricted stock awards for the accelerated vesting date was $ 558 and is included in the general and administrative expenses in the Company’s consolidated income statement. In July 2024, 5 shares vested and 2 shares were withheld in lieu of taxes at a cost of $ 324 on the accelerated vesting date. | text | five | sharesItemType | text: <entity> five </entity> <entity type> sharesItemType </entity type> <context> On June 30, 2024, a named executive officer resigned for “good reason” which, under the terms of his employment agreement, resulted in an acceleration of the vesting of the next tranche of five outstanding restricted stock awards that would have otherwise vested on March 1, 2025. As a result, the incremental share-based compensation expense from the modification on the five restricted stock awards for the accelerated vesting date was $ 558 and is included in the general and administrative expenses in the Company’s consolidated income statement. In July 2024, 5 shares vested and 2 shares were withheld in lieu of taxes at a cost of $ 324 on the accelerated vesting date. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.